BayBridge Capital Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-842	Closed	-$395K	–	102
2024 Q2	$395K	Sell	842 -66	-7%	-$30.9K	0.31%	79
2024 Q1	$363K	Sell	908 -1,742	-66%	-$697K	0.32%	78
2023 Q4	$1.15M	Buy	+2,650	New	+$1.15M	1.07%	23